Cardiovascular Autonomic Deficits in Different Types of Achalasia

Abhijith Anil1, Ritesh K Netam1, Atanu Roy2

  • 1Department of Physiology, All India Institute of Medical Sciences, New Delhi, New Delhi, IND.

Cureus
|June 3, 2024
PubMed

Insights

Achalasia cardia patients show reduced autonomic function, particularly parasympathetic reactivity and sympathetic responses, worsening with disease progression from type II to type I.

Area of Science:

  • Gastroenterology
  • Neurology
  • Cardiology

Background:

  • Achalasia cardia is a primary esophageal motility disorder with unknown progression.
  • Autonomic dysfunction has not been extensively studied across different achalasia types.

Purpose of the Study:

  • To investigate autonomic dysfunction in various types of achalasia.
  • To compare autonomic function in achalasia patients with healthy controls.

Main Methods:

  • Diagnosis of achalasia using high-resolution esophageal manometry (HRM) based on Chicago classification v4.0.
  • Performance of autonomic function tests (AFT) including head-up tilt test, deep breathing test (DBT), Valsalva maneuver (VM), handgrip test (HGT), cold pressor test (CPT), and heart rate variability (HRV) test.
  • Comparison of test results between 62 achalasia patients (types I, II, III) and 39 healthy controls.

Main Results:

  • All achalasia types exhibited a generalized loss of parasympathetic and baroreflex-independent sympathetic reactivity.
  • Baroreflex-dependent cardiovascular adrenergic reactivity remained normal.
  • Cardiac autonomic tone showed reduced parasympathetic and sympathetic influence, though sympathovagal balance was maintained.
  • Autonomic dysfunction severity was higher in type I, followed by type II achalasia.

Conclusions:

  • Achalasia patients demonstrate decreased parasympathetic reactivity, baroreflex-independent sympathetic reactivity, and cardiac autonomic tone compared to controls.
  • The severity of autonomic dysfunction correlates with disease progression, being more pronounced in type I than type II achalasia.

Related Concept Videos

Disorders of the Autonomic Nervous System01:18

Disorders of the Autonomic Nervous System

The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's...
625
Direct-Acting Cholinergic Agonists: Pharmacological Actions00:59

Direct-Acting Cholinergic Agonists: Pharmacological Actions

Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
1.3K
Chemical Synapses01:26

Chemical Synapses

Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
8.8K
Adrenergic Receptors: ɑ Subtype01:31

Adrenergic Receptors: ɑ Subtype

Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
1.5K
Indirect-Acting Cholinergic Agonists: Pharmacological Actions01:30

Indirect-Acting Cholinergic Agonists: Pharmacological Actions

Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
661
Direct-Acting Cholinergic Agonists: Therapeutic Uses01:11

Direct-Acting Cholinergic Agonists: Therapeutic Uses

Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
726